Céruse, Philippe <br/><br/>
A pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multicenter, retrospective study.  [electronic resource] 

 -  Anti-cancer drugs  Sep 2014 
 - 970-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1473-5741 
<br/><br/><label>Standard No.: </label>10.1097/CAD.0000000000000126  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cisplatin--administration & dosage<br/>Combined Modality Therapy<br/>Disease-Free Survival<br/>Docetaxel<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Induction Chemotherapy<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local<br/>Organ Sparing Treatments<br/>Paranasal Sinus Neoplasms--drug therapy<br/>Pyriform Sinus--pathology<br/>Retrospective Studies<br/>Taxoids--administration & dosage